Skip to Content
Merck
  • Changes in transcription and metabolism during the early stage of replicative cellular senescence in budding yeast.

Changes in transcription and metabolism during the early stage of replicative cellular senescence in budding yeast.

The Journal of biological chemistry (2014-10-09)
Yuka Kamei, Yoshihiro Tamada, Yasumune Nakayama, Eiichiro Fukusaki, Yukio Mukai
ABSTRACT

Age-related damage accumulates and a variety of biological activities and functions deteriorate in senescent cells. However, little is known about when cellular aging behaviors begin and what cellular aging processes change. Previous research demonstrated age-related mRNA changes in budding yeast by the 18th to 20th generation, which is the average replicative lifespan of yeast (i.e. about half of the population is dead by this time point). Here, we performed transcriptional and metabolic profiling for yeast at early stages of senescence (4th, 7th, and 11th generation), that is, for populations in which most cells are still alive. Transcriptional profiles showed up- and down-regulation for ∼20% of the genes profiled after the first four generations, few further changes by the 7th generation, and an additional 12% of the genes were up- and down-regulated after 11 generations. Pathway analysis revealed that these 11th generation cells had accumulated transcripts coding for enzymes involved in sugar metabolism, the TCA cycle, and amino acid degradation and showed decreased levels of mRNAs coding for enzymes involved in amino acid biosynthetic pathways. These observations were consistent with the metabolomic profiles of aging cells: an accumulation of pyruvic acid and TCA cycle intermediates and depletion of most amino acids, especially branched-chain amino acids. Stationary phase-induced genes were highly expressed after 11 generations even though the growth medium contained adequate levels of nutrients, indicating deterioration of the nutrient sensing and/or signaling pathways by the 11th generation. These changes are presumably early indications of replicative senescence.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
DL-Tryptophan, ≥99% (HPLC)
Sigma-Aldrich
Sodium trichloroacetate, 97%
Sigma-Aldrich
DL-Tryptophan, ≥99% (HPLC)
Tryptophan, European Pharmacopoeia (EP) Reference Standard
Isoleucine, European Pharmacopoeia (EP) Reference Standard
Leucine, European Pharmacopoeia (EP) Reference Standard
Valine, European Pharmacopoeia (EP) Reference Standard
Supelco
L-Isoleucine, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Supelco
L-Isoleucine, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Isoleucine, 99%, FCC, FG
Sigma-Aldrich
DL-Valine, ReagentPlus®, ≥99.0% (NT)
Sigma-Aldrich
DL-Methionine, ≥99.0% (NT)
Sigma-Aldrich
DL-Cysteine, technical grade
Sigma-Aldrich
DL-Methionine, 99%, FCC, FG
Sigma-Aldrich
DL-Valine, ≥97%
Sigma-Aldrich
DL-Phenylalanine, ReagentPlus®, 99%
Sigma-Aldrich
L-Isoleucine, BioUltra, ≥99.5% (NT)
SAFC
L-Isoleucine
Sigma-Aldrich
L-Isoleucine, reagent grade, ≥98% (HPLC)
Sigma-Aldrich
L-Isoleucine, from non-animal source, meets EP, JP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
Ergosterol, ≥75%
Sigma-Aldrich
DL-Methionine, BioReagent, suitable for cell culture, suitable for insect cell culture, ≥99%
Sigma-Aldrich
DL-Methionine, ≥99%
Sigma-Aldrich
DL-Leucine, ≥99% (HPLC)
Ergosterol, European Pharmacopoeia (EP) Reference Standard
Supelco
Ergosterol, Pharmaceutical Secondary Standard; Certified Reference Material
Methionine, European Pharmacopoeia (EP) Reference Standard
Phenylalanine, European Pharmacopoeia (EP) Reference Standard
DL-Methionine, European Pharmacopoeia (EP) Reference Standard